Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
3(20%)
Results Posted
25%(1 trials)
Terminated
2(13%)

Phase Distribution

Ph phase_3
1
7%
Ph not_applicable
5
33%
Ph phase_2
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

40.0%

4 of 10 finished

Non-Completion Rate

60.0%

6 ended early

Currently Active

3

trials recruiting

Total Trials

15

all time

Status Distribution
Active(4)
Completed(4)
Terminated(6)
Other(1)

Detailed Status

Withdrawn4
Completed4
Terminated2
Active, not recruiting2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
3
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (14.3%)
Phase 31 (14.3%)
N/A5 (71.4%)

Trials by Status

recruiting17%
unknown17%
withdrawn427%
terminated213%
active_not_recruiting213%
completed427%
enrolling_by_invitation17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT03495011

MRI Characterization of Mammographically Detected DCIS

Active Not Recruiting
NCT04871516Not Applicable

Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer

Active Not Recruiting
NCT02086578Phase 2

Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions

Completed
NCT05968157Not Applicable

MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick

Recruiting
NCT05990478

A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer

Withdrawn
NCT03372902

Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening

Completed
NCT06843083

Contrast Enhanced Mammography or Breast Magnetic Resonance: Which Choice for Optimal Diagnostic Performance?

Enrolling By Invitation
NCT05825768Not Applicable

Preoperative Magnetic Resonance Imaging to Obtain Adequate Resection Margins in Breast Conserving Surgery, (PRIMAR) Trial

Terminated
NCT04770714Not Applicable

Prospective Comparison of Breast MRI vs Contrast Mammography Prior to Surgery in Breast Cancer Patients

Withdrawn
NCT03870659

Abbreviated Breast MRI in Cancer Detection

Completed
NCT04468867Not Applicable

Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy

Unknown
NCT00165412

Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

Completed
NCT03158441

DTi Diffusion Findings in Breast MRI Screening and Diagnostic

Withdrawn
NCT00695916Phase 3

MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery

Withdrawn
NCT00925405

Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy

Terminated

All 15 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
15